Skip to main content
SRPT logo
SRPT
(NASDAQ)
Sarepta Therapeutics, Inc.
$23.23-- (--)
Loading... - Market loading

Sarepta Therapeutics (SRPT) Stock Price & Financial Analysis

Sarepta Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.62 - $23.29
52-Week High$64.80
52-Week Low$10.42
Open$21.93
Volume3.15M
Average Volume (3M)3.15M
Market Cap2.43B
Shares Outstanding104.79M
Price to Sales (P/S)1.05
Price to Book (P/B)2.03
EV/EBITDA-4.13
Revenue (TTM)2.20B
Net Income (TTM)-713.41M
Free Cash Flow (TTM)-317.43M
EPS (TTM)$-6.81
Profit Margin-32.45%
Operating Margin-29.99%
Return on Equity (ROE)-62.55%
Debt to Equity0.91
50-Day MA$18.77
200-Day MA$19.41
52-Week Change-64.25%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Sarepta Therapeutics

What is the current stock price for SRPT?

As of the latest trading session, SRPT stock trades at $23.23. The 52-week range is $10.42–$64.80, with a day range of $21.61–$23.29.

What is the P/E ratio for SRPT?

The P/E ratio (Price-to-Earnings) for SRPT is shown in the Key Statistics section. This valuation metric helps compare Sarepta Therapeutics, Inc. to industry peers.

Does SRPT pay dividends?

Sarepta Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SRPT?

Based on 7 analysts, the consensus for SRPT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SRPT?

Sarepta Therapeutics's market capitalization is $2.43B, classifying it as a mid-cap company. Sarepta Therapeutics operates in the Healthcare sector within the Biotechnology industry.